Photobiomodulation (PBM), or low-level-laser therapy (LLLT) has been proven to be a safe and effective treatment for both male and female pattern hair loss in numerous large, high quality clinical trials. This type of therapy uses monochromatic red laser light at a finely-tuned wavelength and intensity to re-energize inactive hair follicles. This red laser light is absorbed by specialized cells deep within the follicle, providing energy to enhance cellular respiration and hair growth. As a result, follicles become awakened from their inactive state and produce thicker, healthier hair.
I knew that I wanted to provide PBM/LLLT as an option to my clients, but wanted to do my due diligence on the different brands and models so that I knew they were getting the most efficacious product. After speaking to several companies, watching conference presentations, and reading clinical data, I decided to work with the LaserCap company. Below are some reasons for my decision:
- aserCap delivers a higher dose of light energy per treatment than all other popular laser therapy devices.
- LaserCap delivers pulsed-wave light emission, which allows the laser diodes to cool during the fraction of a second when they switch off. As a result, when the lasers switch back on, they can deliver light at a higher intensity without excessive build-up of heat.
- LaserCap is portable, making it easier to wear the cap for the recommended session frequency and duration.
All of these factors have been shown to influence the effectiveness of photobiomodulation in the treatment of androgenetic alopecia. In a recent systematic review and analyses of summary-level data, Aditya K Gupta, MD, PhD, concluded that energy fluence (measured by J/cm2), irradiation session duration, and light pulsing has a significant therapeutic effect on AGA.
I will be sharing my experiences using the LaserCap device in the coming months so stay tuned! Let me know if you’d like more information about the different LaserCap models, or if you’re interested in purchasing a device.